Zocor Linked to Muscle Damage and Liver Injuries
Zocor® (simvastatin), a cholesterol-lowering medication that blocks the production of cholesterol in the body, has been linked to liver failure. In March 2010, the FDA warned patients and healthcare providers about the potential for increased risk of muscle injury from Zocor (80mg). Although muscle injury (myopathy) is a known side effect with all statins, this warning highlights the greater risk of developing muscle injury, including rhabdomyolysis, for patients when they are prescribed and use higher doses of this drug.
Zocor and Rhabdomyolysis
Rhabdomyolysis is the most serious form of myopathy and can lead to severe kidney damage, kidney failure, and sometimes even death in Zocor users. Zocor has also been linked to potential risk increases in major cardiovascular events, such as heart attack, revascularization, and cardiovascular death, in those taking higher dosages of 80mg.
If you or someone you know and care for has experienced these or any other side effects while taking Zocor, our Zocor lawyers may help you determine if a Zocor lawsuit would be in your interest. Conact us today, using the form or telephone number on this page.